Clinical Trials · NCT00702845

To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Organon and Co
Enrollment
397
Start date
Dec 2006
Locations
See registry
Primary endpoint
Number of Cumulus-oocyte-complexes Retrieved, Per Attempt
View Gonadorelin compound reference